Immune Checkpoint Inhibitor-Induced Diabetes Mellitus: Potential Role of T Cells in the Underlying Mechanism
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune Checkpoint Inhibitor-Induced Diabetes Mellitus: Potential Role of T Cells in the Underlying Mechanism
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 4, Pages 2093
Publisher
MDPI AG
Online
2021-02-22
DOI
10.3390/ijms22042093
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diabetes mellitus induced by immune checkpoint inhibitors: type 1 diabetes variant or new clinical entity? Review of the literature
- (2021) V. Lo Preiato et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes
- (2020) Z. Quandt et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Cytocidal macrophages in symbiosis with CD4 and CD8 T cells cause acute diabetes following checkpoint blockade of PD-1 in NOD mice
- (2020) Hao Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification and functional characterization of CD8+ T regulatory cells in type 1 diabetes patients
- (2019) Marsha Pellegrino et al. PLoS One
- T-Lymphocyte Infiltration to Islets in the Pancreas of a Patient Who Developed Type 1 Diabetes After Administration of Immune Checkpoint Inhibitors
- (2019) Sho Yoneda et al. DIABETES CARE
- The multifaceted nature of diabetes mellitus induced by checkpoint inhibitors
- (2019) Lucien Marchand et al. ACTA DIABETOLOGICA
- Endocrine‐related adverse events associated with immune‐checkpoint inhibitors in patients with melanoma
- (2019) Eva Kassi et al. Cancer Medicine
- Endocrine‐Related Adverse Events Related to Immune Checkpoint Inhibitors: Proposed Algorithms for Management
- (2019) Jaydira Del Rivero et al. ONCOLOGIST
- Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors
- (2018) Angeliki M. Stamatouli et al. DIABETES
- Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes
- (2018) Kevin C. Osum et al. Scientific Reports
- PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-α and-γ via IRF1 induction
- (2018) Maikel L. Colli et al. EBioMedicine
- Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing
- (2018) Zihai Li et al. Journal of Hematology & Oncology
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- Programmed cell death-1, PD-1, is dysregulated in T cells from children with new onset type 1 diabetes
- (2017) Hector M. Granados et al. PLoS One
- Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents
- (2016) Jeffrey S. Weber et al. ONCOLOGIST
- The Expression of Programmed Death-1 on CD4+ and CD8+ T Lymphocytes in Patients with Type 2 Diabetes and Severe Sepsis
- (2016) Yumei Jia et al. PLoS One
- Expression of PD-1 Molecule on Regulatory T Lymphocytes in Patients with Insulin-Dependent Diabetes Mellitus
- (2015) Valentina Perri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PD-1, but Not PD-L1, Expressed by Islet-Reactive CD4 + T Cells Suppresses Infiltration of the Pancreas During Type 1 Diabetes
- (2013) Kristen E. Pauken et al. DIABETES
- Increased PD-1 on CD4+CD28− T cell and soluble PD-1 ligand-1 in patients with T2DM: Association with atherosclerotic macrovascular diseases
- (2013) Bimin Shi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Endoplasmic reticulum stress response and inflammatory cytokines in type 2 diabetic nephropathy: Role of indoleamine 2,3-dioxygenase and programmed death-1
- (2012) Babak Baban et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes
- (2010) Tae Joon Won et al. ARCHIVES OF PHARMACAL RESEARCH
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epigenetic mechanisms of regulation of Foxp3 expression
- (2009) G. Lal et al. BLOOD
- Protective Role of Programmed Death 1 Ligand 1 (PD-L1)in Nonobese Diabetic Mice: The Paradox in Transgenic Models
- (2008) C.-J. Wang et al. DIABETES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started